329 related articles for article (PubMed ID: 11340382)
21. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium.
Ogura Y; Kimura H
Surv Ophthalmol; 1995 May; 39 Suppl 1():S17-24. PubMed ID: 7660308
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable microspheres in drug delivery.
Okada H; Toguchi H
Crit Rev Ther Drug Carrier Syst; 1995; 12(1):1-99. PubMed ID: 8521523
[TBL] [Abstract][Full Text] [Related]
24. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
[TBL] [Abstract][Full Text] [Related]
25. Soft tissue augmentation using sculptra.
Humble G; Mest D
Facial Plast Surg; 2004 May; 20(2):157-63. PubMed ID: 15643584
[TBL] [Abstract][Full Text] [Related]
26. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable nanoparticles for cytosolic delivery of therapeutics.
Vasir JK; Labhasetwar V
Adv Drug Deliv Rev; 2007 Aug; 59(8):718-28. PubMed ID: 17683826
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-d,l-lactic acid.
Kumanohoso T; Natsugoe S; Shimada M; Aikou T
Cancer Chemother Pharmacol; 1997; 40(2):112-6. PubMed ID: 9182831
[TBL] [Abstract][Full Text] [Related]
29. Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.
Hawley AE; Illum L; Davis SS
FEBS Lett; 1997 Jan; 400(3):319-23. PubMed ID: 9009222
[TBL] [Abstract][Full Text] [Related]
30. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers.
Tabata Y; Ikada Y
J Biomed Mater Res; 1988 Oct; 22(10):837-58. PubMed ID: 3220838
[TBL] [Abstract][Full Text] [Related]
31. Development of biodegradable nanoparticles for liver-specific ribavirin delivery.
Ishihara T; Kaneko K; Ishihara T; Mizushima T
J Pharm Sci; 2014 Dec; 103(12):4005-4011. PubMed ID: 25335768
[TBL] [Abstract][Full Text] [Related]
32. Poly(epsilon-caprolactone) and poly (L-lactic-co-glycolic acid) degradable polymer sponges attenuate astrocyte response and lesion growth in acute traumatic brain injury.
Wong DY; Hollister SJ; Krebsbach PH; Nosrat C
Tissue Eng; 2007 Oct; 13(10):2515-23. PubMed ID: 17655492
[TBL] [Abstract][Full Text] [Related]
33. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
Rotunda AM; Narins RS
Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
[TBL] [Abstract][Full Text] [Related]
34. A microfabrication method of a biodegradable polymer chip for a controlled release system.
Ito Y; Hasuda H; Morimatsu M; Takagi N; Hirai Y
J Biomater Sci Polym Ed; 2005; 16(8):949-55. PubMed ID: 16128230
[TBL] [Abstract][Full Text] [Related]
35. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles.
Dailey LA; Wittmar M; Kissel T
J Control Release; 2005 Jan; 101(1-3):137-49. PubMed ID: 15588900
[TBL] [Abstract][Full Text] [Related]
36. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.
Ibrahim MA; Ismail A; Fetouh MI; Göpferich A
J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349
[TBL] [Abstract][Full Text] [Related]
37. Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres.
Giordano GG; Chevez-Barrios P; Refojo MF; Garcia CA
Curr Eye Res; 1995 Sep; 14(9):761-8. PubMed ID: 8529414
[TBL] [Abstract][Full Text] [Related]
38. Modeling of drug release from bioerodible polymer matrices.
He J; Zhong C; Mi J
Drug Deliv; 2005; 12(5):251-9. PubMed ID: 16188723
[TBL] [Abstract][Full Text] [Related]
39. New biodegradable polymers for injectable drug delivery systems.
Jeong B; Choi YK; Bae YH; Zentner G; Kim SW
J Control Release; 1999 Nov; 62(1-2):109-14. PubMed ID: 10518642
[TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro characterization of dexamethasone-loaded poly(D,L-lactic acid) microspheres embedded in poly(ethylene glycol)-poly({varepsilon}-caprolactone)-poly(ethylene glycol) hydrogel for orthopedic tissue engineering.
Fan M; Guo Q; Luo J; Luo F; Xie P; Tang X; Qian Z
J Biomater Appl; 2013 Aug; 28(2):288-97. PubMed ID: 22561978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
